SureTrader
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

totally agree with that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 212
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 8, 2016 "PR Newswire (US)" - 2/1/2016 6:00:00 AM
ImmunoCellular Therapeutics Enters into a Sponsored Research Agreement with The University of Maryland, Baltimore to Pursue M... "PR Newswire (US)" - 1/27/2016 6:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2016 6:05:59 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2016 6:04:11 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 1/20/2016 6:01:47 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/12/2016 1:08:37 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 12/30/2015 6:04:01 AM
ImmunoCellular Therapeutics Establishes Agreement with The Canadian Brain Tumour Consortium for ICT-107 Phase 3 Registrationa... "PR Newswire (US)" - 12/14/2015 6:00:00 AM
ImmunoCellular Therapeutics Establishes Agreement with Alliance Foundation Trials, LLC for ICT-107 Phase 3 Registrational Tri... "PR Newswire (US)" - 12/7/2015 6:00:00 AM
ImmunoCellular Therapeutics Establishes Agreement with EORTC for ICT-107 Phase 3 Registrational Trial in Glioblastoma "PR Newswire (US)" - 12/1/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/25/2015 6:20:17 AM
ImmunoCellular Therapeutics to Host Conference Call and Webcast to Discuss ICT-107 Program in Newly Diagnosed Glioblastoma on... "PR Newswire (US)" - 11/23/2015 4:05:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 11/23/2015 10:19:15 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/23/2015 6:04:43 AM
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase 2 Survival and Immune Response Data at the Society for Neuro-Oncol... "PR Newswire (US)" - 11/20/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/19/2015 4:18:41 PM
ImmunoCellular Therapeutics Enters into Sponsored Research Agreement with University of Texas MD Anderson Cancer Center to Ad... "PR Newswire (US)" - 11/12/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/10/2015 4:33:04 PM
ImmunoCellular Therapeutics Announces Third Quarter 2015 Financial Results "PR Newswire (US)" - 11/10/2015 4:05:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2015 6:17:43 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/30/2015 4:18:10 PM
ImmunoCellular Therapeutics to Report Third Quarter 2015 Financial Results on November 10, 2015 "PR Newswire (US)" - 10/27/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/7/2015 4:23:24 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 10/6/2015 4:18:48 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2015 2:13:49 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist